DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Arrowhead Pharmaceuticals Q1 EPS $(0.03) Misses $(0.01) Estimate, Sales $29.45M Miss $29.5M Estimate

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by 200 percent. This is a 123.08 percent decrease over earnings of $0.13 per

Benzinga · 02/05/2020 21:00

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by 200 percent. This is a 123.08 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $29.45 million which missed the analyst consensus estimate of $29.5 million by 0.17 percent. This is a 15.03 percent decrease over sales of $34.658 million the same period last year.